Alopecia and Grey Hair Are Associated with COVID-19 Severity

    October 2020 in “ Experimental Dermatology ”
    Paulo Müller Ramos, Mayra Ianhez, Hélio Amante Miot
    Image of study
    TLDR Having a lot of gray hair and hair loss are linked to more severe COVID-19.
    In a study by São Paulo State University involving 43,595 participants from Brazil, researchers discovered that alopecia and extensive gray hair were independently linked to more severe COVID-19 cases. The study analyzed responses from 39,789 controls, 2,332 suspected, and 1,474 confirmed COVID-19 cases, finding a higher prevalence of both conditions in confirmed patients. While confirming known risk factors such as older age, hypertension, obesity, diabetes, and heart disease, the study also identified extensive gray hair and alopecia as additional independent risk factors for severe COVID-19. Despite limitations like the absence of dermatological examination and non-discrimination of alopecia types, the associations' magnitude and corroboration with suspected cases lent credibility to the findings.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

      community How do we only have two treatments to combat hair loss at this point in time?

      in Chat  211 upvotes 1 year ago
      The post discusses frustration over the limited and not always effective treatments for hair loss, mainly Minoxidil and Finasteride. The conversation includes mentions of potential new treatments like GT20029, HMI-115, CosmeRNA, KX-826, and microneedling, but also highlights the challenges of funding and prioritizing research in this area.

      community Pyrilutamide Phase 3 on its way

      in Treatment  127 upvotes 2 years ago
      Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  449 upvotes 2 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

      community RT1640 - Gray Hair Reversal Recipe

      in Research/Science  3 upvotes 2 years ago
      The conversation discusses a hair loss treatment formulation containing cyclosporin, minoxidil, and tacrolimus, and mentions ongoing research on hair color reversal. The treatment showed high efficacy in restoring hair color in trials with 40 to 50 people.

      community New Treatments, and a Huge Group Buy with Lots of Research

      in Research/Science  109 upvotes 1 year ago
      A user is organizing a group buy for various compounds aimed at reversing hair loss and gray hair, and improving brain health and fat loss. The user has developed a treatment plan based on extensive research and is inviting others to participate, with the option to choose only the compounds they need.

    Similar Research

    5 / 1000+ results